{"filing":{"accession_number":"0001493152-26-024723","cik":"0002030763","ticker":"WGRX","company_name":"Wellgistics Health, Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226024723/form8-k.htm"},"events":[{"id":9516,"run_id":8346,"accession_number":"0001493152-26-024723","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"The filing discloses entry into a Fully Binding Letter of Intent (Term Sheet) dated May 20, 2026, involving a material multi-party transaction. The Company would acquire or license intellectual property from EOS and SCLX, expand its Datavault license, and acquire a controlling interest in Health Lives Here from HBA. Upon conversion of Acquisition Preferred, the transaction parties would own approximately 89.6% of the Company's common stock, representing a substantial change of control. The proposed combined entity valuation is stated at $4.0 billion. While subject to definitive agreements and conditions, this constitutes entry into a material definitive agreement for M\u0026A activity under Item 1.01.","company_name":"Wellgistics Health, Inc.","ticker":"WGRX","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":1173,"accession_number":"0001493152-26-024723","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"The filing discloses entry into a Fully Binding Letter of Intent (Term Sheet) dated May 20, 2026, involving a material multi-party transaction. The Company would acquire or license intellectual property from EOS and SCLX, expand its Datavault license, and acquire a controlling interest in Health Lives Here from HBA. Upon conversion of Acquisition Preferred, the transaction parties would own approximately 89.6% of the Company's common stock, representing a substantial change of control. The proposed combined entity valuation is stated at $4.0 billion. While subject to definitive agreements and conditions, this constitutes entry into a material definitive agreement for M\u0026A activity under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T03:01:19.703104+00:00","company_name":"Wellgistics Health, Inc.","ticker":"WGRX","filing_date":"2026-05-21"}]}